by Samme Jancin | Jul 13, 2015
Since 2007, FDA has been issuing priority review vouchers for pharmaceutical products. In 2015 the newest priority review vouchers to focus on reducing time and cost of drug development. Developing a new drug takes a lot of time and money. In the United States, about...
by Samme Jancin | Jul 13, 2015
The fight continues. Recent efforts have been made (again!) to repeal the tax on medical device companies, which was a provision in the Affordable Care Act. The revenue from this tax is estimated at about $30 billion in the next ten years. Those in favor of the tax...
by Samme Jancin | Jul 13, 2015
SumofUs, an environmentalist group, wants the good manufacturing practices (GMP) to include environmental impact in their guidelines. Both the environmentalist group and industry believe that the Pharmaceuticals Supply Chain Initiative (PSCI) does not go into enough...
by Samme Jancin | Jul 13, 2015
A Missouri Congressman has proposed a bill which would allow Pharmaceutical companies place more content online. Rep. Bill Long (R-MO) originally discovered the lack of presence on social media from these companies while working on the 21st Century Cures Act. One of...
by Samme Jancin | Jul 10, 2015
Pearl Pathways announces the hiring of Patti Hunker, a senior leader in clinical research and management of foundation as Clinical Research Advisor. Hunker has over 10 years of clinical research experience in both drug and device trials. Previously, she held positions...
